In vivo angiogenesis assay

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5382514
SERIAL NO

07862622

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of performing in vivo angiogenesis assays which involves the use of a matrix material which can be maintained in an injectable solution form at a temperature below that of a host and which forms a gel matrix when injected into a host. The matrix material is an extract of murine basement membrane. Angiogenic factors, including inducers and inhibitors can be added to the matrix material prior to injection into a host. After a period of time within the host, the gel matrix is recovered and angiogenesis of the recovered matrix gel is quantitated. The procedure can be used to induce vascularization or inhibit vascularization at a tissue situs as desired.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICESC/O NATIONAL INSTITUTES OF HEALTH OFFICE OF TECHNOLOGY TRANSFER BOX OTT BETHESDA MD 20892

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Martin, George R Bethesda, MD 39 692
Passaniti, Antonino Baltimore, MD 5 126

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation